Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Catabasis Pharmaceuticals
Catabasis Pharmaceuticals
Reports Graph
Compounds that leverage the therapeutic potential of Omega-3 fatty acids and other clinically validated compounds to create new medicines for the treatment of: inflammatory bowel disease (IBD), severe hypertriglyceridemia & dyslipidemia, multiple sclerosis (MS), chronic kidney disease (CKD), psoriasis, and an ultra-orphan metabolic disease
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next